Deb Chakravarti, a professor with industry experience, discusses the FDA's oversight of phenylephrine in cold medicines. They explore historical cases like thalidomide and Vioxx, while also highlighting new technologies like a capsule to prevent opioid overdose. The episode reveals the complexities of drug approval and regulations, as well as innovative solutions for healthcare challenges.